报价延迟最少15分钟:2026/08/07 12:56 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.98 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.88/0.59
|
|
企业价值
67.97M
|
| 资产负债 |
|
每股账面净值
2.97
|
| 现金流量 |
|
现金流量率
0.16
|
| 损益表 |
|
收益
1.02M
|
|
每股收益
0.28
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC. |
